EP4321157
NÝ NOTKUN Á SAMSETNINGU ANGÍÓTENSÍN VIÐTAKABLOKKARA (ARB) MEÐ HLUTLAUSUM INNRÆNUM PEPTÍÐASIBLOKKARA (NEPI)
:
EP einkaleyfi í gildi á Íslandi:
26.8.2014:
23.10.2024:
23202190.7
:
3.2.2025:
15.3.2025
:
25.8.2034:
25.8.2025
:
NEW USE OF A COMBINATION OF AN ANGIOTENSIN RECEPTOR BLOCKER (ARB) WITH A NEUTRAL ENDOPEPTIDASE INHIBITOR (NEPI)
26.8.2014
23.10.2024
3.2.2025
15.3.2025
25.8.2025
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
SHI, Victor Chengwei:
New Jersey, US
:
LEFKOWITZ, Martin:
New Jersey, US
:
RIZKALA, Adel Remond:
New Jersey, US
:
Zacco Denmark A/S:
Arne Jacobsens Allé 15, DK
:
PCT/US2013/056680:
26.8.2013:
WO
:
201461972933 P:
31.3.2014:
US
:
A61K 31/194, A61K 31/197, A61K 31/216, A61K 31/41, A61K 31/221, A61K 45/06, A61K 31/401, A61K 31/225, A61P 9/12, A61P 9/10